The Hepatobiliary Surgery Department at the First Affiliated Hospital of Chongqing Medical University is one of leading specialty across mainland China. Awarded with national clinical key specialty and the only one clinical key specialty in great Chongqing area. It serves as a training base for standardized diagnosis and treatment of primary liver cancer in China and also as one of the quality control center in liver and pancreatic cancer standardized management since the National Health Commission started to build such clinical quality control centers in China. As a hapatobiliary and pancreatic surgery department with national reputation, we hold the chairman position of the Upper Yangtze River Cholangiopancreatography (ERCP) Surgery Alliance, Organ Transplantation and General Surgery Quality Control Center (including liver, pancreas, and small intestine transplantation), Liver Cancer Quality Control Center, and the Hepatobiliary Surgery Branch of the Medical Association in great Chongqing area.
We are dedicated to offer high standard and personalized care to our patients, provide rigorous training for young surgeons across the country, conduct research in clinical and basic science. As a leading center for the surgical treatment of liver, gallbladder, biliary tract, pancreas, and spleen diseases, the department is renowned for high volume complex hepatobiliary and pancreatic surgical procedures. The department opens 233 beds in three branches: Main Campus (143 beds), Yuzhong Campus (45 beds), and Jinshan Campus (45 beds), which makes the department the largest center in Chongqing to serve more than 32 million local people and patients from other cities, provinces and countries. Our annual outpatient visit is over 50,000. More than 7,000 procedures are performed. Last year, we conducted over 800 heaptectomies, majority of which were laparoscopic procedures, 1,500 endoscopic procedures for gallbladder and pancreas diseases (ERCP , ENBD, EST, Stenting), over 1,200 radiology intervention therapy for liver and biliary diseases, and more than 150 laparoscopic pancreatic surgeries. About 18% of our patients came from area outside great Chongqing.
The Hepatobiliary Surgery Department is equipped with state of art equipments, including the Da Vinci Surgical System, 3D and 4K fluorescence laparoscopy, BK ultrasound, low-dose X-ray machine, SpyGlass endoscope, and an department owned operating room for cholangiopancreatography (ERCP) procedures. Organ transplantation and minimally invasive surgical techniques are the key areas of development in hepatobiliary surgery, more than 95% of our procedures are completed in minimal invasive approach. Complex procedures, such as DCD liver transplantation, living donor liver transplantation, minimally invasive liver transplantation, various types of laparoscopic and robotic hepatectomies, radical surgery for hilum cholangiocarcinoma, pancreaticoduodenectomy, duodenum preserving pancrea head resection, vascular resection and reconstruction for liver, and pancreatic surgeries, endocsopic therapy for hepatobiliary and pancreatic duct stones and heaptobiliary-pancreatic tumors. Additionally, the department offers interventional treatments for portal hypertention (TIPS), cholangitis (PTSCS), sever type pancreatitis , as well as liver, biliary tract,gallbladder, and pancreatic tumors.
Over 90% of the surgeons in the Hepatobiliary Surgery Department hold Ph D. diploma, and our surgeons regularly participate in exchanges and study programs at renowned domestic and international universities specializing in hepatobiliary surgery. The department is maintaining collaboration with institutions such as Kyoto University and the University of Tokyo in Japan, the University of Strasbourg in France, the University of Pittsburgh and the University of California in the United States, Zhejiang University, Sun Yat-sen University, and Renji Hospital affiliated with Fudan University. The department currently has 4 doctoral supervisors, 8 master's supervisors, 9 professors, 9 associate professors, and several attending and resident surgeon trainees. We have trained over a hundred master's and doctoral candidates who sucessfully earn their diploma.
The Hepatobiliary Surgery Department has undertaken and completed several key projects funded by the National Natural Science Foundation of China and provincial-level departments, with a total funding of 15.22 million yuan. They have published 171 research papers in SCI journals. The department organizes an annual academic conference on hepatobiliary and pancreatic surgery. In recent years, they have been honored with one second-class prize for technological advancement by the Chongqing Science and Technology Commission and one first-class prize for medical and pharmaceutical scientific achievements by the Chongqing Health Bureau. They have also contributed to the compilation of multiple surgical monographs.